# Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement.

> **NCT05169229** · PHASE2,PHASE3 · RECRUITING · sponsor: **University Hospital, Linkoeping** · enrollment: 1100 (estimated)

## Conditions studied

- Arthroplasty, Replacement, Hip
- Osteoarthritis, Hip
- Antibiotic Resistant Infection
- Prosthetic Joint Infection

## Interventions

- **DRUG:** Vancomycin + Tobramycin
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT05169229
- **Lead sponsor:** University Hospital, Linkoeping
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-04-01
- **Primary completion:** 2028-12
- **Final completion:** 2031-12
- **Target enrollment:** 1100 (ESTIMATED)
- **Last updated:** 2025-07-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05169229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05169229, "Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05169229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*